Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease
Clinical trial NCT07547930 · RECRUITING
Trial details
- NCT number
- NCT07547930
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-24
- Primary completion
- 2027-12-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.